Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies. (2022)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/raf-22-0020
PubMed Identifier: 35928672
Publication URI: http://europepmc.org/abstract/MED/35928672
Type: Journal Article/Review
Volume: 3
Parent Publication: Reproduction & fertility
Issue: 3
ISSN: 2633-8386